Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Timing of primary tumor resection after systemic chemotherapy initiation among patients with metastatic colon cancer.
Authors
Munir Buhaya
Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX
Munir Buhaya , Baqir Jafry , Syed Mohammad Ali Kazmi , Emina Huang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 65)
DOI
10.1200/JCO.2024.42.3_suppl.65
Abstract #
65
Poster Bd #
E8
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Comparison of irinotecan and oxaliplatin as adjuvant chemotherapy for patients with resectable synchronous colon cancer plus liver-confined metastases: A retrospective nationwide database study.
First Author: Yi-Hsin Liang
Poster
2014 ASCO Annual Meeting
Extended follow-up following aggressive resection of locally recurrent rectal cancer.
First Author: Francis Si Wai Zih
Poster
2014 ASCO Annual Meeting
Surveillance for asymptomatic recurrence in resected stage III colon cancer (CC): Does it result in a more favorable outcome?
First Author: Martin Smoragiewicz
Poster
2023 ASCO Annual Meeting
Adjuvant systemic chemotherapy with or without hepatic arterial infusion of floxuridine in patients following colorectal cancer liver metastases resection (HARVEST): A prospective, randomized controlled trial.
First Author: Yu-hong Li